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1. Introduction 
Toll-like receptors (TLRs) are essential in the host defense against microbial 
pathogens. TLRs have emerged as the key sensors of microbial products, as they are 
expressed on sentinel cells in the immune system, most notably on dendritic cells and 
macrophages, and on epidermal cells as well, where they sense a range of chemicals produced 
by bacteria, viruses, fungi and protozoa [1, 2, 3]. To date 11 members of the human TLR 
family have been identified (TLR 1-TLR 11). The interaction between a TLR and a microbial 
component triggers the activation of the innate immune system, as well as the development of 
acquired immunity. Bacterial or mycobacterial lipopeptides, lipoteichoic acid, the yeast cell-
wall component zymosan, or glycerophosphatidylinositol anchors from parasites are 
recognized by TLR2, while bacterial lipopolysaccharide (LPS) is recognized by TLR4. 
Structurally, TLR family members are characterized by the presence of an extracellular 
domain consisting of 19-25 tandem copies of leucine-rich repeat (LRR) motif and a highly 
conserved intracellular Toll-interleukin-1 receptor (TIR) domain. While the extracellular part 
is responsible for specific ligand-recognition, the intracellular part mediates the signal 
transduction. Recognition of pathogen-associated molecular patterns (PAMPs) by TLRs, 
either alone or in heterodimerization with other TLRs (TLR2/TLR1 or TLR2/TLR6) or non-
TLR type coreceptors (TLR4/CD14/MD2), culminates in the activation of the transcription 
factor N F - K B and the MAP kinases resulting in the activation of genes important for an 
effective host defense, especially those of proinflammatory cytokines (Fig. 1.) [2, 4], 
Keratinocytes and vaginal epithelial cells, which have been shown to express several TLRs 
[3, 5], have a considerable role in the initiation of host defense against infections through 
producing various kinds of cytokines, chemokines and antibacterial peptides. Participating in 
innate immune processes, epidermal and epithelial cells can contribute to the pathogenesis of 
numerous skin diseases, such as acne. Concerning the functions of TLR2 and TLR4 in 
epidermal and epithelial tissues we have proposed to investigate the following topics: 
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NF-vB-binding motif 
Fig. 1. Toll-like receptor signalling [4], 
1.1 Effect of immunomodulators on the immune functions of keratinocytes 
The skin represents the largest organ in the body, providing the principal physical 
barrier to the environment. Keratinocytes comprise 90% of the cells found in the epidermis 
and are capable of eliciting an immune response. They respond to nonspecific external stimuli 
with the production of inflammatory cytokines, adhesion molecules and chemotactic factors. 
Interleukin-1 (IL-1) and tumor necrosis factor a (TNF-a) have been called primary cytokines, 
activate several cellular signaling pathways, including the nuclear factor-KB ( N F - K B ) 
pathway that regulates the genes for chemokines, cytokines, defensins, E-selectin, 
intercellular adhesion molecule 1 and vascular-cell adhesion molecule 1 among others [3, 6-
9]. IL-1 is present in keratinocytes constitutively, but upregulation has been observed upon 
stimulation with lipopolysaccharide (LPS), physical, chemical or thermal injury, ultraviolet 
irradiation or a variety of cytokines (i.e. GM-CSF, TNF-a, IL-6, TGF-a, and IL-1 a and IL-ip 
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itself). IL-8, a powerful neutrophil attractant, and TNF-a productions are also increased after 
various stimuli [10, 11]. 
Cytokines are not the only means of inducing N F - K B responses in keratinocytes. In the 
past several years studies have demonstrated that epidemial keratinocytes express at least 
seven members (TLR1, TLR2, TLR3, TLR4, TLR5, TLR6 and TLR9) of the human TLR 
family suggesting an important role for keratinocytes in cutaneous host defense [3], Recently, 
it has been shown that keratinocytes express both TLR2 and TLR4 at the mRNA and protein 
levels in vitro; TLR2 and TLR4 are present in the normal human epidermis in vivo; and their 
expression is regulated by microbial components [12]. Data indicate that TLR4 primarily 
mediates cellular signaling induced by Gram-negative bacteria while TLR2 is implicated in 
the recognition of multiple products of Gram-positive bacteria, mycobacteria and yeast [1,3]. 
Pathogen-associated molecular patterns of microorganisms induce the production of 
proinflammatory cytokines (e.g. TNF-a), chemokines (e.g. IL-8) and antimicrobial peptides 
(e.g. hBD2) in keratinocytes through the activation of TLRs (Fig. 2.). 
Fig. 2. Multiple roles of keratinocytes in the cutaneous immune response against infection [3]. 
The HaCaT keratinocyte cell line is a spontaneously transformed human epithelial cell 
line derived from a histologically normal skin specimen of the distant periphery of a 
melanoma, which maintains full epidermal differentiation capacity [13]. Despite the altered 
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and unlimited growth potential, HaCaT cells, similarly to normal keratinocytes, form an 
orderly structured and differentiated epidermal tissue, when transplanted onto nude mice. 
Differentiation-specific keratins (nos. 1 and 10) and other markers (involucrin and filaggrin) 
are expressed and regularly located. The non-tumorigenic HaCaT cells are commonly used for 
gene transfection studies or as a model system to study hyperproliferative skin diseases such 
as psoriasis, or to study cancer development [14, 15]. Cultured HaCaT cells are also 
frequently employed for studies of epidermal immune functions. [16-18] 
Drugs, which are used in the topical treatment of inflammatory skin diseases such as 
psoriasis or atopic dermatitis, have a relevant influence on the immune functions of 
keratinocytes. Glucocorticoids are well-known anti-inflammatory agents, while tacrolimus 
(FK506) is the first of a new class of non-steroidal topical immunomodulators. 
Glucocorticoids interact with the intracellular GC receptor (GR), which causes 
activation of the receptor and its translocation to the nucleus, where it regulates the expression 
of several genes. Induction or suppression by GR may occur through several different 
mechanisms, such as direct binding to GC responsive elements in GC-sensitive gene 
promoters; protein-protein interaction with positive regulators, e.g. AP-1, forming an inactive 
complex; or induction of the I-KB inhibitory protein expression, through which GR 
functionally inhibits the N F - K B induced genes [ 1 9 - 2 2 ] , 
Tacrolimus, a macrolide immunosuppressant, in T lymphocytes forms a complex by 
binding to an intracellular protein, FK506 Binding Protein (FKBP), thereby inhibiting the 
phosphatase activity of calcineurin, and subsequently preventing the dephosphorylation of the 
transcription factor Nuclear Factor of Activated T cells (NFAT) [23, 24]. Dephosphorylation 
of NFAT leads to its translocation to the nucleus where it forms a complex with another 
transcription factor, AP-1, and binds to the enhancer region of cytokine genes. FKBP 12, 
calcineurin B and NFAT1 are expressed by cultured human keratinocytes. Calcineurin is 
revealed to be functionally active in human keratinocytes inducing nuclear translocation of 
NFAT1 that is inhibited by tacrolimus [25]. 
In our study we have compared the effects of budesonide and tacrolimus on the 
production of IL- la , TNF-a and IL-8 and on the expression of TLR2 and TLR4 in normal 
human isolated keratinocytes and in HaCaT cells. Cells were co-incubated with these agents 
for various times. The effects of the immunosuppressants were compared on unstimulated 
isolated keratinocytes and on isolated keratinocytes after LPS stimulation, used as a model of 
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bacterial infection. We have also investigated the influence of budesonide and tacrolimus on 
the NF-kB activation after LPS and TNF-a induction in transfected HaCaT keratinocytes. 
1.2 Effect of microbial agents on the immune functions of vaginal epithelial cells 
The mucosal surface of the lower female genital tract not only provides a barrier 
against the outside world, but also participates in innate immune defense. Epithelial cells 
represent the predominant cell types that initially come into contact with microbial pathogens 
and play a role in immune cell recruitment and immunoregulation. This hypothesis is 
supported by the results of several authors. Candida albicans and Streptococcus aureus 
strains and superantigens were shown to upregulate the expression of chemokine and cytokine 
genes in reconstituted human vaginal epithelium and in human vaginal epithelial cell line [16, 
27]. Besides, TLR2 and TLR4 mRNAs and proteins were detected in human female 
reproductive tract [28]. Immortalized human vaginal epithelial cell line was shown to express 
characteristic markers for basal epithelial cells, K5 and K14, and a characteristic marker for 
suprabasal nonkeratinizing squamous epithelium K13 [29]. These cells are also capable to 
secrete various soluble immunological mediators under basal culture conditions and after 
stimulation with exogenous cytokines [30]. Therefore this cell line provides a suitable model 
system to study the immunological functions of vaginal cells. 
We have found that TLR2 and TLR4 receptors are expressed in vivo in the vaginal 
epithelia and in vitro in PK E6/E7 vaginal epithelial cell line. The mRNA expression of IL-8 
and TNF-a was significantly upregulated in PK E6/E7 cells after treatment with LPS, a 
Gram-positive bacterial cell wall component peptidoglycan (PGN), zymosan or heat-killed 
Candida albicans (C. albicans). LPS, PGN and C. albicans also increased the mRNA level of 
human p-defensin 2 (hBD2), however only C. albicans treatment enhanced significantly the 
IL- la mRNA expression. The Mycobacterium tuberculosis cell wall extract tuberculin had no 
effect on the investigated genes. The changes in hBD2 mRNA level were confirmed at the 
protein level as well by immunocytochemistry. We also investigated the effect of the 
microbial agents above on the protein expression of IL-8, IL- la and TNF-a of the cells by 
ELISA to confirm our mRNA expression results. 
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1.3 Examination o/TLR2 and TLR4 polymorphisms in acne 
Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit affecting 
most of the teenagers and several adults. For most patients, acne is limited to occasional flares 
of comedones and pustules, however in severe cases, host inflammatory response can result in 
painful nodules and disfiguring scars. Acne is a multifactorial disease, traditional etiologic 
factors include increased sebum production, ductal hyperkeratosis, colonization with 
Propionibacterium acnes (P. acnes) and production of inflammatory mediators, but, 
according to twin studies, genetic factors also contribute to the development of the symptoms 
[31-34], 
In the case of multifactorial diseases the presence of several predisposing gene 
alterations assists the environmental factors in eliciting the symptoms. Up to now only a few 
suspected genes have been investigated in connection with acne susceptibility [35-38]. Toll-
like receptors (TLRs) are expressed on the surface of several immune cells and they are 
responsible for the recognition of microbial molecular patterns. Since TLR2 and TLR4 affect 
immune processes, they may play a role in the pathogenesis of acne. TLR2 and TLR4 
expression was found to be increased in the epidermis of acne lesions in vivo [39], 
furthermore, TLR2 was expressed on the cell surface of macrophages surrounding 
pilosebaceous follicles and P. acnes induced the cytokine production of monocytes through a 
TLR2-dependent pathway [40]. 
Here we have investigated two mutations of the TLR2 gene (C2179T in the 
NM 003264.2 sequence and rs5743708 causing the aminoacid changes Arg677Trp and 
Arg753Gln, respectively) as well as two polymorphisms of the TLR4 gene (rs4986790 and 
rs4986791 causing the aminoacid changes Asp299Gly and Thr399Ile, respectively) in 101 
Caucasian subjects, 63 with acne vulgaris and 38 healthy controls. These polymorphisms have 
been suggested to be associated with several infectious diseases [41], Because the two single 
nucleotide polymorphisms (SNPs) of the human TLR4 gene - Asp299Gly and Thr399Ile -
are situated within the extracellular domain of TLR4, the immunological impact is most likely 
caused by a decreased recognition of ligands. The studied nonsynonymous TLR2 SNPs are 
within the conserved C-terminal region of human TLR2, which mediates the signal 
transduction (Fig. 3.). 
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Fig. 3. Position of known SNPs within the coding sequences of TLR2 and TLR4 [41], SNPs 
exhibiting allele frequencies greater than 2% are shown by full lines, frequencies less than 2% 
by broken lines. LRR=proposed leucine-rich repeats; M=proposed membrane-spanning 
region; TIR=Toll/interleukin-l receptor domain. 
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2. Aims 
The aims of our study were: 
• to compare the effects of 25 nM and 250 nM budesonide and 25 nM and 250 nM 
tacrolimus on the production of IL- la , TNF-a and IL-8 and on the expression of 
TLR2 and TLR4 in HaCaT keratinocytes. 
• to compare the effects of 250 nM budesonide and 250 nM tacrolimus on the 
production of I L - l a , T N F - a and I L - 8 and on the expression of T L R 2 and T L R 4 in 
isolated human keratinocytes and on the N F - K B activation after L P S and T N F - a 
induction in transfected HaCaT keratinocytes. 
• to assess the biological relevance of TLR2 and TLR4 expression in vaginal epithelial 
cells by investigating the effect of microbial agents on IL-8, I L - l a and TNF-a protein 
expression in these cells. 
• to investigate the association of two polymorphisms of the TLR2 gene and two 
polymorphisms of the TLR4 gene with acne vulgaris. These polymorphisms have been 
suggested to be associated with the susceptibility to several infectious diseases. 
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3. Materials and Methods 
3.1 Materials 
LPS (purified from E. coli; 026:B6), Staphylococcus aureus peptidoglycan (PGN), and 
zymosan (Saccharomyces cerevisiae) was purchased from Sigma (St Louis, MO). Candida 
albicans (0656 CBS Delft) was cultured on Sabourand agar and transferred to fresh agar 
24 hours prior to the experiments. Candida cell suspension was prepared in Keratinocyte-
SFM, the cells were killed by incubating them for 30 min at 56 °C. Mycobacterium 
tuberculosis cell wall extract was purchased from Human Ltd, (Gödöllő, Hungary). The 
extract contains the 19 kDa antigen of M. tuberculosis. Ethanol (absolute, reagent grade) was 
purchased from Spektrum-3D (Debrecen, Hungary). Budesonide was provided by Gedeon 
Richter, Ltd (Budapest, Hungary), and tacrolimus by Fujisawa Healthcare, Inc (Deerfield, IL). 
LPS was dissolved in PBS at the concentration of 10 mg/ml. Budesonide and tacrolimus were 
dissolved in 96% ethanol at concentrations of 25 pM and 1 mM, respectively. Stock solutions 
were further diluted with hydrocortisone free KGM-2 keratinocyte medium to the desired 
final concentrations. Human recombinant TNF-a was prepared as described previously [42], 
3.2 Cell culture 
3.2.1 HaCaT keratinocytes 
Cells of the spontaneously transformed human keratinocyte cell line HaCaT (kindly 
provided by N.E. Fusenig, Heidelberg, Germany) were cultured in high-glucose DMEM 
(Invitrogen Corporation, Carlsbad, CA), supplemented with 10% fetal bovine serum (FBS) 
(Invitrogen Corporation), 1% 200 mM L-glutamine and 1% antibiotic/antimycotic solution 
(Sigma) (complete DMEM) at 37°C in a humidified atmosphere containing 5% C0 2 . The 
medium was changed every 2 days. Vehicle (1 v/v% ethanol), 25 nM and 250 nM budesonide 
°r 25 nM and 250 nM tacrolimus were diluted with complete DMEM then added to the 
culture. Supernatants and cells - homogenized in TRIzol reagent (Invitrogen Corporation) -
were collected 3, 6, 12, 24 and 48 hours after addition of budesonide and tacrolimus. 
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3.2.2 Isolated keratinocytes 
Human epidermal cells were obtained from healthy individuals undergoing plastic 
surgery after informed consent according to Institutional Review Board protocol. After 
removal of the subcutaneous tissue and much of the reticular dermis tissue, samples were cut 
into small strips and incubated in Dispase solution (grade II; Roche Diagnostics, Mannheim, 
Germany) overnight at 4°C. On the following day, the epidermis was peeled off the dermis. 
The epidermis was incubated in 0.25% trypsin solution (Sigma) at 37°C for 20 min and 
aspirated using a Pasteur pipette to aid cell dissociation. A suspension of primary epidermal 
cells was prepared in Keratinocyte-SFM medium (Invitrogen Corporation) supplemented with 
1% 200 mM L-glutamine and 1% antibiotic/antimycotic solution (Sigma) (complete 
Keratinocyte-SFM medium). Epidermal cells were seeded into 75 cm2 tissue culture flasks 
(Corning, Corning, NY) at a density of 7xl04 cells/cm2 in complete Keratinocyte-SFM. 
Human epidermal keratinocytes were cultured in complete Keratinocyte-SFM in a humidified 
atmosphere containing 5% C0 2 . The medium was changed every 2 days. In our experiments, 
third-passage keratinocytes were used at 70-80% confluence. 24 hours before treatment the 
culture medium was replaced with hydrocortisone free KGM-2 keratinocyte medium 
(Cambrex Corporation, East Rutherford, NJ) supplemented with 1% 200 mM L-glutamine. 
Vehicle (1 v/v% ethanol), 250 nM budesonide or 250 nM tacrolimus with or without 
5 fig/ml LPS were diluted with hydrocortisone free KGM-2 medium then added to the culture. 
Supernatants and cells (homogenized in TRIzol reagent) were collected 3, 6, 12, 24 and 48 
hours after addition of budesonide, tacrolimus and LPS. 
3.2.3 Vaginal epithelial cells 
The immortalized human vaginal epithelial cell line (PK E6/E7 cells) was a kind gift 
of Professor Schaeffer (North-western University Medical School, Chicago, IL) [29]. PK 
E6/E7 cells were cultured in complete Keratinocyte-SFM medium in a humidified atmosphere 
containing 5% C02 . 
PK E6/E7 cells were treated with either LPS (1 pg/ml), PGN (5 pg/ml), heat-killed C. 
albicans (10 Candidal PK E6/E7 cell), zymosan (10 pg/ml), tuberculin (5 pg/ml) or with 
microbial compound-free control medium for 0, 3, 6, 12 or 24 hours. After the indicated 
times, cells and supernatants were collected for further analysis. 
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3.3 Real-time RT-PCR 
Total RNA was isolated with TRIzol reagent (Invitrogen Corporation) according to the 
manufacturer's instructions. RNA concentration was determined by the A26o value of the 
sample. First strand cDNA was synthesized from 1.5 pg total RNA with Promega (Promega 
U.S., Madison, WI) ImProm-II Reverse Transcription System using a 10:1 mixture of 
oligo-dT and random hexamer primers. 2-4 pi of the cDNA synthesis products was used as 
templates in real-time PCR (iCycler IQ Real Time PCR; Bio-Rad, Hercules, CA) assays to 
I quantify the relative mRNA levels of the genes of interest. TaqMan probes were used for TLR2, TLR4, IL-8 mRNAs and 18S rRNA while TNF-cc and IL- la mRNAs were quantitated using SYBR-Green. The following primer sets and TaqMan probes were used for RT-PCR assays: TLR2 forward: TTTCACTGCTTTCAACTGGTA, TLR2 reverse: 
TGGAGAGGCTGATGATGAC, TLR2 TaqMan probe: 
FAM/CAAGACCCACACCATCCACAA-BHQ-1/; TLR4 forward: 
CGATTCCATTGCTTCTTG, TLR4 reverse: GCTCAGGTCCAGGTTCTT, TLR4 TaqMan 
Probe: FAM/CAATGCATGGAGCTGAATTTCT-BHQ-1/; IL-8 forward: 
CCACACTGCGCCAACA, IL-8 reverse: GCATCTTCACTGATTCTTGGAT, IL-8 TaqMan 
probe: FAM/CTGGGTGC AG AGGGTTGTGG-BHQ-1 / ; 18S RNA forward: 
CGGCTACCACATCCAAGGAA, 18S RNA reverse: GCTGGAATTACCGCGGCT, 18S 
RNA TaqMan probe: TexRed/ TGCTGGCACCAGACTTGCCCTC-BHQ-1 / ; TNF-a 
forward: TCTCCTTCCTGATCGTGGC, TNF-a reverse: GGTTCAGCCACTGGAGCT ; 
IL- la forward: CAATTGTATGTGACTGCCCAAG, IL - l a reverse: 
ATAGTTCTTAGTGCCGTGAGTT. PCR reactions were performed in duplicates. Reaction 
mixtures without cDNA were used as negative control. 
3.4 ELIS A 
IL-8, TNF-a and IL - l a protein levels in cell culture supernatants were measured using 
the Quantikine human IL-8, TNF-a and IL-la immunoassay kits (R&D Systems, 
Minneapolis, MN) and the Biosource TNF-a EASIA kit (Biosource, Nivelles, Belgium) 
following the manufacturer's instructions. Color intensity was measured as the absorbance at 
450 nm. According to the manufacturer, the minimum detectable concentrations were 
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10pg/ml, 44.4 pg/ml and 1 pg/ml for IL-8, TNF-a and IL- l a , respectively for Quantikine 
kits, and 3 pg/ml for Biosource TNF-a kit. 
3.5 Flow cytometry 
TLR2 flow cytometry was performed using a monoclonal mouse anti-human TLR 2.1 
antibody (mAb, eBioscience, San Diego, CA). 500.000 cells were washed in PBS containing 
BSA then incubated with TLR2 mAb conjugated with FITC for 30 min at room temperature. 
After washing, membrane stained cells were fixed in 1% paraformaldehyde at 4°C until 
analyzed. For intracellular staining, cells were fixed in 4% paraformaldehyde after membrane 
staining, treated with permeabilization buffer (0.1% saponine in phosphate-buffered saline 
containing 0.1% sodium azide and 1% FCS) and stained again with the FITC conjugated 
TLR2 mAb for 30 min at room temperature. After washing, membrane+intracellular stained 
cells were fixed in 1% paraformaldehyde and stored at 4°C until analysis. Negative controls 
were prepared by incubating with an isotype-matched control mouse immunoglobulin. To 
confirm that the staining protocol was adequate, peripheral blood lymphocytes - which 
strongly express TLR2 - were stained with the same method. Scanning and analysis were 
carried out using FACScalibur (Becton Dickinson, San Jose, CA) and CellQuest software 
(Becton Dickinson). Results were expressed as the geometric mean fluorescence intensity 
(MFI) ratio calculated by the MFI of cells stained with an antigen-specific antibody divided 
by the MFI of cells stained with the isotype-matched control antibody. 
3.6 NF-KB reporter assay 
The effect of budesonide and tacrolimus on LPS and T N F - a induced N F - K B activation 
was measured using HaCaT cells stably transformed with the NF-xB/luc/neo reporter plasmid 
(kindly provided by Zsuzsanna Gyorfy, Institute of Biochemistry, Biological Research 
Center, Hungarian Academy of Sciences, Szeged, Hungary). A neomycine resistance gene of 
the pRc/CMV plasmid (Invitrogen Corporation) was integrated into the original Stratagene 
PNF-KB/1UC reporter plasmid (PathDetect® N F - K B CA-Reporting System). Cells were seeded 
at 3xio 5 per well in a 24-well plate in DMEM:F12 1:1 medium (Invitrogen Corporation) 
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supplemented with 10% fetal bovine serum (Hyclone, Logan, UT) and 1% 
antibiotic/antimycotic solution (Sigma) and were stimulated 12 hours later with 5 pg/ml LPS 
or 5 ng/ml human recombinant TNF-a. The treated cells were lysed, and the luciferase 
activities in lysates were measured using the Promega Luciferase Assay System according to 
the manufacturer's instructions (Promega). 
3.7 Patients and methods for TLR genotyping 
Acne vulgaris diagnosis was defined as a physician's diagnosis. Acne patients were 
subclassified into three groups, as having severe symptoms (acne conglobata group n=17), 
medium symptoms (acne papulo-pustulosa group, n=39) and mild symptoms (acne 
comedonica group, n=7). Control group comprised patients showing no symptoms of acne 
during their life. 
We isolated genomic DNA from whole blood obtained from the study subjects, using 
the Perfect gDNA Blood Mini Isolation Kit (Eppendorf AG, Hamburg, Germany) and 
Generation Capture Column Kit (Gentra Systems, Inc., Minneapolis, MN) according to the 
manufacturer's instructions. Informed consent was obtained from each individual before 
sample collection and the study was conducted according to the Helsinki Declarations. Primer 
sets were designed by Primer3 software at http://frodo.wi.mit.edu/cgi-bin/primer3 such that 
products did not exceed 300 bp and synthesized by Oligonucleotide Laboratory, Biological 
Research Center of the Hungarian Academy of Sciences (Szeged, Hungary). PCR was 
performed in a total volume of 50 pi containing 200 ng of template DNA, 1-1 pi of 
10 pmol/pl primers and 25 pi REDTaq ReadyMix PCR Reaction Mix (Sigma-Aldrich Co., St. 
Louis, MO). The cycling profile involved denaturation at 95°C for 30 sec, annealing at 57°C 
for 30 sec and extension at 72°C for 1 min for 40 cycles. Final extension was continued at 
72°C for 10 min. The amplification was carried out in a MyCycler Thermal System (Bio-Rad, 
Hercules, CA). PCR products were purified by Quantum Prep PCR Kleen Spin Columns 
(Bio-Rad) according to the manufacturer's instructions. The alleles of TLRs were confirmed 
by sequencing (Agricultural Biotechnology Center, Godollo, Hungary) and analysed by 
BioEdit program (Ibis Therapeutics, Carlsbad, CA). 
To assess the effect of the studied TLR polymorphisms on the protein structure and 
function, an in silico analysis was performed. We used PolyPhen software (http://tux.embl-
heidelberg.de/ramensky/polyphen.cgi) to predict the possible impact of an amino acid 
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substitution on the protein. This calculation is based on the observation that the studied 
substitution is rarely or never detected in the family of homologous proteins [43], Changes in 
protein hydrophilicity resulted from the occurrence of the studied SNPs were observed at the 
homepage http://bioinformatics.org/JaMBW, which uses the Hopp and Wood algorithm to 
determine the charged areas of a protein. 
3.8 Data presentation 
PCR results were expressed as fold increases over the 0 hour or control values. Data 
were presented as mean ± standard error of mean (SEM) for n experiments. Flow cytometry 
data were expressed as the geometric mean fluorescence intensity (MFI) ratio. Data were 
compared using one-way analysis of variance (ANOVA) followed by Dunnett's post hoc test 
or Mann-Whitney U test to determine statistical differences after multiple comparisons 
(SPSS, SPSS Inc., Chicago, IL). Probability values of less than 0.05 for parametric tests and 
less than 0.005 (for keratinocytes experiments) or 0.05 (for vaginal epithelial cell 
experiments) for nonparametric tests were considered significant. 
The statistical analysis of allele frequency data was performed using the statistical 
homepage f a c u l t y . v a s s a r . e d u / l o w r y / V a s s a r S t a t s . h t m l . Data were compared using Fisher exact 
probability test, a p value less than 0.05 was considered significant. 
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4. Results 
Effects of immnnemodulators on keratinocytes 
4-l.l TLR2 and TLR4 mRNA expressions are suppressed by tacrolimus in HaCaT 
keratinocytes 
The effects of the immunosuppressive drugs budesonide and tacrolimus on the 
constitutive gene expressions of IL-8, TNF-a and IL- la and the Toll-like receptors 2 and 4 
were examined in HaCaT keratinocytes. HaCaT cells were treated with 25 nM and 250 nM 
budesonide or 25 nM and 250 nM tacrolimus or with solvent. Samples were collected 3, 6, 12, 
24 and 48 hours after treatment and were subjected to real-time RT-PCR. IL-8 mRNA was 
sbghtly suppressed after the treatment with both concentrations of budesonide (Fig. 4B). A 
s %ht increase in TLR2 mRNA was noticed in two out of three experiments in HaCaT cells at 
24 hours of coincubation with the steroid, mainly when it was applied at the higher 
concentration. Furthermore, 250 nM tacrolimus significantly decreased the mRNA 
expressions of TLR2 and TLR4, while it did not change the expressions of the other examined 
genes (Fig. 4D, E). Neither drugs influenced the mRNA levels of IL- la and TNF-a. 
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Fig. 4. Constitutive expressions of TLR2 and TLR4 mRNAs were inhibited significantly by 
tacrolimus. Expressions of IL-la (A), IL-8 (B), TNF-cc (C), TLR2 (D) and TLR4 (E) genes 
were analyzed by real-time RT-PCR. Total RNA from HaCaT keratinocytes incubated with 
chicle, budesonide or tacrolimus for the given times was reverse transcribed and subjected to 
real-time RT-PCR The levels of mRNAs were normalized to the 18S rRNA, and are 
Presented as fold increases over the 0-hour values. The chart shows the mean ± SEM of four 
independent experiments (*: p<0.05 vs. vehicle treated control, Dunnett test). 
41.2 Budesonide significantly decreased the IL-8 protein expression in HaCaT 
keratinocytes 
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To confirm that changes in cytokine mRNA expressions in HaCaT keratinocytes 
caused by the treatment with the two immunosuppressants, ELISA was carried out from the 
cell culture supernatants of cells. IL-8 protein levels were reduced 12 hours after treatment 
with 25 nM and 250 nM budesonide, while tacrolimus did not have a significant effect 
(Fig. 5.). Neither drugs affected the IL-la protein production; furthermore, TNF-a 
concentration was below the detection limit in these experiments (data not shown). 
2000 
control budesonide budesonide tacrolimus tacrolimus 
Fig. 5. IL-8 protein production in HaCaT keratinocytes was inhibited by budesonide. HaCaT 
keratinocytes were incubated with vehicle, budesonide or tacrolimus for the given times. The 
amount of IL-8 protein in the supernatants was measured by ELISA. The charts show the 
mean ± SEM of three independent experiments. (*: p<0.05 vs. vehicle treated control, 
Dunnett test). 
4.1.3 IL-8 and TNF-a mRNA expressions are suppressed, TLR2 mRNA expression is 
induced by budesonide, but not by tacrolimus, in cultured human keratinocytes 
In order to examine the effect of the budesonide and tacrolimus on the constitutive 
expression of pro-inflammatory cytokines IL-8, TNF-a and IL-la and the TLR2 and TLR4, 
subconfluent cultures of keratinocytes were incubated with 250 nM budesonide or 250 nM 
tacrolimus and subjected to real-time RT-PCR. Samples were collected 3, 6, 12, 24 and 48 
hours after addition of drugs, vehicle treated samples were used as controls. The amount of 
IL-8 and TNF-a mRNA were decreased significantly and a moderate fall in case of IL-la 
mRNA was noticeable at 6 hours after co-incubation with 250 nM budesonide (Fig. 6A, B, 
c)- At the subsequent time points the values returned to control values. TLR2 expression has 
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increased 5-6 fold following the first 3 hours of co-incubation with the steroid and remained 
elevated up to 24 hours (Fig. 6D). There were no changes in the mRNA expression of TLR4 
(Fig. 6E). Tacrolimus had no effect on the expression of the examined genes. 
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Fig. 6. Constitutive expressions of IL-8, TNF-a and TLR2 mRNAs were influenced by 
budesonide, but not by tacrolimus. Expressions of IL-la (A), IL-8 (B) TOF-cc (C), TLR2 (D) 
and TLR4 (E) genes were analyzed by real-time RT-PCR. Total RNA from third passage 
isolated keratinocytes incubated with vehicle, budesonide or tacrolimus for the given times 
was reverse transcribed and subjected to real-time RT-PCR. The levels of mRNAs were 
normalized to the 18S rRNA, and are presented as fold increases over the 0-hour values. The 
chart shows the mean ± SEM of four independent experiments (*: p<0.05 vs. vehicle treated 
control, Dunnett test). 
4-1.4 Budesonide slightly hindered the LPS induced increase of IL-8 expression but 
elevated the mRNA level of TLR2 
To investigate whether the drugs are able to suppress LPS induced immune responses 
in keratinocytes, cells were stimulated with 5 pg/ml LPS in the presence of 250 nM 
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budesonide, 250 nM tacrolimus or solvent. Samples were collected 3, 6, 12, 24 and 48 hours 
after treatment and subjected to real-time RT-PCR analyses. LPS significantly induced the 
expression of IL-la, IL-8 and TNF-a, and slightly increased the amount of TLR4 mRNA 
(Fig. 7A, B, C, E). Induction of IL-8 and TNF-a was pronounced, about 20-25 fold at the 
earliest time point and remained elevated up to 24 hours. As the different individual 
measurements resulted in different degrees of inductions the obtained standard deviations 
were relatively large. Neither drugs influenced the LPS induced transcription level of TLR4 
and the proinflammatory cytokines IL-la and TNF-a. A moderate decrease in the amount of 
LPS induced IL-8 mRNA was observed after co-incubation with budesonide for 3 or 6 hours 
(Fig. 7B), while the glucocorticoid significantly increased the TLR2 expression during the 
first 24 hours of co-incubation with LPS (Fig. 7D). 
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Fig. 7. LPS induced IL-la, IL-8, and TNF-a mRNA expressions, budesonide slightly 
inhibited this increase in the case of IL-8 expression, while increased the TLR2 expression. 
Total RNA from third passage isolated keratinocytes incubated with vehicle, budesonide or 
tacrolimus in the presence of LPS for the given times was reverse transcribed and subjected to 
real-time RT-PCR. The levels of mRNAs were normalized to the 18S rRNA, and are 
Presented as fold increases over the vehicle treated samples, respectively. The chart shows the 
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mean ± SEM of three independent experiments (• : p<0.05 vs. vehicle treated control 
indicated only in cases of LPS induced samples, *: p<0.05 vs. LPS induced samples, Dunnett 
test). 
4.1.5 Suppressive effect of budesonide on IL-8 expression was also revealed at the protein 
level in cultured keratinocytes 
To determine whether down-regulation of cytokine genes is accompanied by 
diminished protein levels, ELISA was carried out. In unstimulated keratinocytes budesonide 
and tacrolimus did not alter significantly the IL-8 or IL-la protein levels. When the cells were 
treated with LPS an approximately fourfold induction was observed in the amount of IL-8 
protein after 12-48 hours of incubation (Fig. 8A), however the mild induction in IL-la 
expression seen at the mRNA level could not be detected at the protein level (Fig. 8B). IL-8 
assay showed that LPS induction of IL-8 protein was significantly decreased in the presence 
of budesonide 12-48 hours after treatment while tacrolimus had no effect. The concentration 
of TNF-a protein - similarly to the HaCaT cell experiments - was below the detection limit in 
the supernatants of cells with both ELISA kits used for TNF-a detection 
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Fig. 8. LPS induced the IL-8 production in isolated keratinocytes, which was inhibited by 
budesonide, while IL- la production was unchanged. Third passage keratinocytes were 
incubated with vehicle, budesonide or tacrolimus with or without LPS. The amounts of IL-8 
(A) and IL-la (B) in the supernatants were measured by ELISA. The charts show the mean ± 
SEM of three independent experiments. (•: p<0.05 vs. vehicle treated control indicated only 
in cases of LPS induced samples, *: p<0.05 vs. LPS induced samples, Dunnett test). 
41.6A moderate increase in the level of TLR2 protein was observed in LPS stimulated cells 
after co-incubation with budesonide 
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36 hours after incubation of normal human keratinocytes with budesonide, tacrolimus 
or solvent in the presence or absence of LPS, cells were trypsinized and stained with FITC 
conjugated TLR2 mAb. Both membrane and membrane+intracellular staining procedures 
were performed. Staining of cells showed no detectable amount of TLR2 on the cell 
membrane even after LPS induction, however a strong intracytoplasmic TLR2 expression was 
observed (Fig. 9., Fig. 10.). LPS treatment alone did not increase the expression of 
intracellular TLR2 protein, but LPS together with budesonide caused a moderate elevation 
(Fig. 9B). Tacrolimus did not influence the expression of TLR2 protein. 
To exclude that trypsin exposure resulted in the removal of TLR2 from the cell surface 
Peripheral blood samples were hemolyzed, treated with trypsin under the same conditions 
than keratinocytes then stained with FITC-conjugated anti-human TLR2 mAb and the 
corresponding isotype control. There was no difference between the staining of trypsin treated 
blood lymphocytes and untreated control samples suggesting that trypsinization did not affect 
the membrane expression of TLR2 (data not shown). 
Fig. 9. 250 nM budesonide together with LPS moderately increased the expression of the 
intracytoplasmic TLR2 protein. Membrane+intracytoplasmic TLR2 in normal human 
keratinocytes was stained and analyzed by flow cytometry after incubation with solvent, 
budesonide (A), LPS or LPS and budesonide (B) for 36 hours. 
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Fig- 10. MFI ratio of isolated keratinocytes stained for either membrane or 
membrane+intracellular detection with mouse anti-human FITC-TLR2 mAb 36 hours after 
treatment with solvent, 250 nM budesonide, 250 nM tacrolimus, 5 pg/ml LPS, and LPS 
together with budesonide or tacrolimus. The chart shows the mean ± SEM of four 
independent experiments for tacrolimus and LPS + tacrolimus treated samples and six 
independent experiments for the other samples. (*: p<0.05 vs. vehicle treated control, Dunnett 
test) MFI ratio: geometric mean fluorescence intensity (MFI) of cells stained with the antigen-
specific antibody divided by the MFI of cells stained with isotype-matched control mouse 
nnmunoglobulin. 
4.1.7 Budesonide significantly inhibited the NF-KB-dependent luciferase reporter activity 
oftransfected HaCaT cells 
In order to investigate whether topical immunomodulators have an effect on N F - K B 
activation in keratinocytes, a luciferase reporter gene assay was performed. HaCaT 
keratinocytes were stably transfected with an NF-KB-luciferase reporter construct and 
transfectants were treated with LPS or TNF-cc, known inducers of NF-KB, in the presence or 
absence of budesonide or tacrolimus (Fig. 11.), or remained untreated for 12 hours. Results of 
the assays demonstrated that TOF-a induced a marked activation of N F - K B in keratinocytes, 
which was significantly inhibited by budesonide. LPS slightly increased the luciferase activity 
in keratinocytes, which was also significantly inhibited by budesonide suggesting that this 
drug has a suppressive effect on keratinocyte immune functions (Fig. 11.). In both LPS and 
TNF-a treated cells ethanol alone reduced the activity of NF-KB. In contrast to budesonide, 
tacrolimus had no effect on N F - K B activation in keratinocytes after LPS or T N F - a treatment. 
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Fig. 11. 250 nM budesonide, but not 250 nM tacrolimus, significantly inhibited the 
NF-KB-dependent luciferase reporter activity of HaCaT cells 12 hours after induction with 
5 ftg/ml LPS (A) or 5 ng/ml human recombinant TNF-a (B). The charts show the mean ± 
SEM of four independent experiments. (*: p<0.005 vs. LPS+ethanol (solvent) or 
TNF-a+ethanol treated samples, Mann-Whitney U test) Thick line represents the luciferase 
activity of LPS+ethanol or TNF-oc+ethanol treated cells, which is equal to 100. 
4-2 Effect of microbial compounds on IL-8, IL-laand TNF-a protein expression 
in vaginal epithelial cell line 
To assess the biological relevance of TLR2 and TLR4 expression in vaginal epithelial 
cells, we investigated the effects of microbial compounds on the protein expression of IL-8, 
IL-la and TNF-a. We also investigated if these changes were in agreement with our mRNA 
* 
results. The IL-8 secretion of vaginal epithelial cells was significantly induced by LPS, PGN, 
zymosan and heat-killed C. albicans, while tuberculin treatment had no effect as 
demonstrated by ELISA (Fig. 12.). The concentration of IL-8 in the supernatant of PK E6/E7 
cells constantly increased until the last time point we analyzed (24 hours). Although LPS, 
P ° N , C. albicans and zymosan significantly induced the expression of TNF-a at the mRNA 
level, TNF-a protein was not detectable in the cell culture supernatants although we tried two 
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different ELISA assays from different manufacturers. Changes in IL-la protein expression 
were not significant after stimulation with microbial compounds. 
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Fig. 12. Microbial compounds representing Gram-negative, Gram-positive bacteria and 
fungal pathogens induced IL-8 protein production in vaginal epithelial cells. Concentrations 
°f IL-8 (A) and IL-la (B) were measured by ELISA in the supernatants obtained from 
cultured immortalized vaginal epithelial cells treated with LPS, PGN, heat-killed C. albicans, 
zymosan and mycobacterial cell wall extract (TUB). Concentrations are shown as picograms 
of protein per ml of supernatant. Data are presented as mean ± SEM of n>3 experiments. A 
statistical analysis was performed, asterisks represent significant differences compared to 
0-hour values (p<0.05). 
,4.3 Examination o/TLR2 and TLR4 polymorphisms in acne 
4.3.1 The prevalence of the studied TLR2 and TLR4 alleles in acne patients was similar to 
the prevalence of these alleles found in healthy individuals. 
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Allele frequencies of the studied SNPs of TLR4 gene causing the amino acid changes 
Asp299Gly and Thr399Ile in the acne vulgaris and control group are shown in Table 1. The 
two studied polymorphisms of TLR4 gene occurred simultaneously (n=l l ) composing a 
haplotype. Furthermore, the individuals carrying these alleles were all heterozygotes for both 
TLR4 SNPs in our study population. These findings correspond with the data in the literature 
[44, 45], There were no statistical differences in the prevalence of these two polymorphisms 
between the control and acne vulgaris groups, even if acne vulgaris group was divided into 
subclasses according to the severity of symptoms. The frequencies of the observed alleles 
were in good agreement with data from the database of National Heart, Lung and Blood 
Institute, Programs for Genomic Applications (IIPGA, www.innateimmunity.net). 
The studied mutations of the TLR2 gene have not occurred in our study population 
(Table 2.). The mutation causing the Arg753Gln amino acid change has a low prevalence 
according to the databases as well. Furthermore, when we had just completed the sequencing 
of our samples, Malhotra et al. [46] have proved that the mutation causing the Arg677Trp 
change, which had been described in 2001 [47], was not a true polymorphism, but a 
sequencing error. 
Table 1. 
TLR4 Asp299Gly 
acne vulgaris control USA* 
(n=63) (n=38) (n=47) 
A: 0.952 0.934 0.904 
G: 0.048 0.066 0.096 
TLR4 Thr399lle 
acne vulgaris control USA* 
(n=72) (n=39) (n=47) 
0.958 0.936 0.947 
0.042 0.064 0.053 
*: from the database of IIPGA, www.innatelmmunity.net 
Table 1. Allele frequencies of the observed polymorphisms (rs4986790 and rs4986791) in 
1LR4 gene causing the aminoacid changes Asp299Gly and Thr399Ile, respectively. 
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Table 2. 
TLR2 Arq677Trp 
acne vulgaris control 
(n=63) (n=38) 
SNP is not detected 
TLR2 Arq753Gln 
acne vulgaris control USA* 
(n=63) (n=38) (n=89) 
G: SNP is not detected 0.977 
A: 0.023 
*: from the database of IIPGA, www.innateimmunity.net 
Table 2. Allele frequencies of the observed mutations (C2179T in the NM_003264.2 
sequence and rs5743708) in TLR2 gene causing the aminoacid changes Arg677Trp and 
Arg753Gln, respectively. 
4.3.2 In silico analysis 
With in silico analysis, TLR2 Arg677Trp and Arg753Gln amino acid changes were 
predicted to be probably and possibly damaging to the protein function, respectively. 
Furthermore, the studied amino acid changes in TLR2 protein were predicted to result in a 
considerable alteration in the hydrophilicity of the protein, while the studied SNPs of TLR4 
didn't have a significant impact on the TLR4 protein (Fig. 13.). 
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Fig. 13. Arg677Trp and Arg753Gln aminoacid changes of TLR2 protein caused a 
considerable alteration in the hydrophilicity of the protein (A), however the studied aminoacid 
changes of TLR4 didn't have a significant impact on the TLR4 protein (B) as it was seen at 
the http://bioinformatics.org/JaMBW homepage. The figure shows a 200-bp aminoacid 
sequence of the TLR2 and TLR4 protein. 
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5. Discussion 
5.1 Effects of immunemodulators on keratinocytes 
Immunosuppressants used topically in several inflammatory skin diseases can 
influence the function of professional immune cells (e.g. lymphocytes) infiltrating the skin, 
but they can also affect the immune functions of keratinocytes. In this study we investigate 
the effects of budesonide and tacrolimus, which use different signalling pathways to exert 
their immunomodulatory effects, on the IL- la , IL-8, TNF-a production and TLR2 and TLR4 
expression of keratinocytes. 
We used HaCaT keratinocytes for our first experiments. These cells are considered to 
be good models of normal human keratinocytes, they are easily available and relatively easy 
to work with. The immunosuppressants were used at 25 nM and 250 nM concentrations. 
250 nM tacrolimus significantly decreased the mRNA expressions of TLR2 and TLR4; 
furthermore, both concentrations of budesonide decreased the IL-8 mRNA and protein levels 
of cells. There were no significant changes in the expression of other observed genes ( IL- la 
and TNF-a) in HaCaT keratinocytes. 
Human keratinocytes isolated from normal skin and cultured in vitro were also used to 
compare the effects of 250 nM of budesonide and tacrolimus on the IL- la , IL-8, TNF-a 
Production and TLR2 and TLR4 expression. We found that budesonide suppressed both 
constitutive and LPS induced IL-8 mRNA expression of keratinocytes. It was also 
demonstrated that budesonide suppressed LPS stimulated IL-8 protein expression. TNF-a 
mRNA expression was decreased in unstimulated keratinocytes, while TLR2 mRNA 
expression was markedly enhanced in unstimulated and LPS treated cells after incubation 
with budesonide. The increase in TLR2 mRNA expression was also detectable at the protein 
level in LPS stimulated cells. Tacrolimus had no effect on IL- la , IL-8, TNF-a production and 
TLR2 and TLR4 expression of cells. Budesonide, but not tacrolimus, significantly inhibited 
the NF-KB-dependent luciferase reporter activity in HaCaT cells after induction with LPS or 
TNF- a . 
Although steroids and tacrolimus use different signaling pathways to develop their 
effects, it is known that both can inhibit IL-ip production in LPS stimulated human 
monocytic cell line [48] and IL-2, IL-3, IL-4, IL-5, IFN-y production in peripheral blood 
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mononuclear cells stimulated with anti-CD3/CD2 [49], In a comparative study the effects of 
10-1000 nM tacrolimus and 1000 nM dexamethasone were examined on passively sensitized 
human lung tissue after exposure to mite antigen. Both agents caused a significant inhibition 
of TNF-a and IL-5 mRNA expression and protein production [50], The effects of 
immunosuppressants on inflammatory signals of keratinocytes have been examined with and 
without stimulation of the cells, but the results are contradictory. Michel et al. have shown 
that IL-8 mRNA levels were decreased in normal human keratinocytes after treatment with 
o v er 50 nM tacrolimus for 1-3 hours [51], however Kaplan et al. showed no effect on 
keratinocyte IL-8 protein after 1-5000 nM tacrolimus treatment for 24 hours [52], In another 
experiment 10-1000 nM tacrolimus has significantly upregulated the release of transforming 
growth factor-p ( T G F - P ) in the presence of T N F - a in keratinocytes, at the same time it 
downregulated the mRNA and protein expression of inducible nitric oxide synthase (iNOS) 
[53], It has also been demonstrated that glucocorticoids (0.1-1000 nM) by themselves could 
augment the production of IL- la by PAM 212 cells (murine epithelial cell line) at both the 
Protein and mRNA levels after 6 hours of co-incubation. When these cells were stimulated for 
2 4 hours with haptens or irritants, which alone increased the IL- l a production, 
glucocorticoids synergistically enhanced the effect [54, 55]. N F - K B activation was also 
revealed in parallel with these observations, nevertheless Lukiw et al. showed inhibition of 
DNA binding of N F - K B by 100 nM budesonide epimer R and dexamethasone in keratinocytes 
activated by IL-ip or platelet-activating factor (PAF) [21]. The discrepancies may be due to 
the different experimental settings, e.g. different sampling time points, different cell types and 
concentrations of immunosuppressants used in the experiments. 
In our experiment we applied 250 nM budesonide or tacrolimus on keratinocytes with 
°r without stimulation with 5 pg/ml LPS, because it has been previously reported that 250 nM 
concentration of either tacrolimus or steroids were effective in keratinocytes and other cell 
types in influencing various immune functions of cells, such as DNA binding activity of 
transcription factors, IL-8 mRNA production, TGF-(3 or iNOS expression in keratinocytes; 
Proliferation of peripheral blood T-lymphocytes; or TNF-a and IL-5 expression of passively 
sensitized lung tissues [21, 50, 51, 53, 56]. It is also known that LPS used in the range of 0.1-
1 0 ftg/ml can induce the IL-8 production of human keratinocytes [57], Tacrolimus was shown 
to decrease the viability of normal human keratinocytes over 1000 nM concentration [52, 53], 
I n Preliminary experiments we have checked the toxicity of the 250 nM of budesonide and 
tacrolimus on normal human keratinocytes and found no toxic effect (data not shown). With 
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the choice of 250 nM budesonide and tacrolimus we had a concentration that was expected to 
be effective enough to cause a suppression without being toxic to the cells. 
Activation of N F - K B represents a central event in the innate immune response of 
keratinocytes [3], In our study 250 nM budesonide significantly inhibited the activation of 
N F - K B after treatment with LPS or T N F - a , while tacrolimus showed no effect. Although the 
LPS induction of N F - K B was not satisfactorily measurable in our assay, the slight induction 
observed was still inhibited by budesonide. These data correspond to the inhibition of both the 
constitutive as well as the LPS induced cytokine expression in keratinocytes by budesonide, 
but not by tacrolimus. 
In our study we were not able to measure TNF-a protein in the supernatants, using 
two different TNF-a ELISA kits, even after LPS induction, although we detected a significant 
induction of TNF-a mRNA in the cells after LPS treatment. Some authors had similar 
difficulties with the detection of TNF-a in the supernatants of unstimulated cultured human 
keratinocytes by ELISA [57, 58]. Treatment with staphylococcal enterotoxin B, all-trans 
retinoic acid, phorbol-myristate-acetate and 10 mJ/cm2 UVB resulted in the appearance of a 
small amount of TNF-a (6-25 pg/ml) detectable by ELISA in the supernatants of cultured 
keratinocytes [58, 59]. Pertussis toxin, diphtheria toxin or killed Staphylococcus species 
however did not show an effect on keratinocyte TNF-a production [57, 58], At the same time 
Graham et al. observed TNF-a protein production both in control cells and keratinocytes 
stimulated with viable and nonviable Propionibacterium acnes [60], 
The expression of TLR2 protein on keratinocytes has been shown by several 
investigators using immunohistochemistiy [12, 61, 62], The presence of TLR2 on the 
membrane of keratinocytes was also demonstrated by flow cytometry [63], On the BEAS-2B 
transformed human bronchial epithelial cell line a strong increase in TLR2 surface expression 
has been shown by flow cytometry in TNF-a and IFN-y stimulated cells after 1 pM 
dexamethasone treatment [64], Furthermore, 1 pM dexamethasone synergistically enhanced 
the nontypeable Haemophilus influenzae-induced mRNA and protein expression of TLR2 on 
human cervix epithelial cell line (HeLa) via specific up-regulation of MAPK phosphatase-1 
(MKP-1) that led to dephosphorylation and inactivation of P 38 MAPK, the negative regulator 
for TLR2 expression [65, 66], It has also been found that dexamethasone enhanced the IL-1 (3-
induced TLR2 r e g u l a t i o n in the same cells using Western blot analysis [67]. In our study, 
budesonide showed similar effect on both unstimulated and LPS induced cultured human 
keratinocytes at the mRNA level generating a 3- to 5-fold TLR2 induction over the vehicle 
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heated samples. However, a mild, but significant stimulating effect of budesonide on the 
Protein expression was only revealed in the LPS induced cells. It has been shown that 
glucocorticoids also act by posttranscriptional mechanisms. In human monocytes, 
betamethasone was found to have a pronounced inhibitory effect on iNOS protein synthesis 
and decrease iNOS protein stability on rat renal mesangial cells [68]. Similar data have been 
reported for endotoxin-induced TNF-a expression in monocytes, where the inhibition of 
translation appeared to be the predominant mode of steroid action [69]. Steroids might 
influence the translation of TLR2 also and might contribute to the poor increase in TLR2 
P^tein expression seen after budesonide treatment despite the strong increase in the TLR2 
mRNA level. 
We could detect only cytosolic TLR2 protein in our cultured keratinocytes. These cells 
represent the proliferating, undifferentiated cell population of keratinocytes. There is evidence 
that an increase in the cell surface TLR2 expression occurs in HaCaT keratinocytes in parallel 
With differentiation [18]. It is possible that in cultured keratinocytes the TLR2 membrane 
exPression or the receptor transport to the cell surface is also restricted to the more 
differentiated cells. 
Based on its general and wide-range suppressive effects on immune cells one would 
exPect that steroids would inhibit most immune functions in keratinocytes as well. A well 
^ o w n side effect of steroids is the occurrence of steroid acne, frequently seen during 
tystemic therapy. Gram-positive Propionibacterium acnes is likely to contribute to the 
characteristic inflammatory response in acne. As TLR2 can recognize Gram-positive bacterial 
Cell wall components [1, 3, 12], it is possible that overexpression of TLR2 on keratinocytes 
a f ter steroid treatment plays a role in the pathological inflammatory reaction to P. acnes seen 
m acne patients. On the other hand, topical corticosteroids may exacerbate cutaneous 
infections [70], which adverse effect might be partly due to the inhibitory effect of 
corticosteroids on the cytokine expression of keratinocytes suppressing the immune functions 
°f cells. 
In most inflammatory skin conditions cytokines released by keratinocytes participate 
i n ^ e development of skin inflammation. The fast occurring antiinflammatory effect that 
t0Pically applied budesonide exerts on the skin could be partially due to its inhibition of the 
cytokine production by keratinocytes. The antiinflammatory action of tacrolimus takes a 
t°nger time to occur, maybe because it does not alter the cytokine production of keratinocytes. 
0 u r results show that tacrolimus and budesonide affects keratinocytes differently. 
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5-2 Effect of microbial compounds on IL-8, IL-laand TNF-a protein expression 
m vaginal epithelial cell line 
Vaginal epithelium has a powerful innate immune system that protects the female 
^productive organs from bacterial and fungal infections. In our study, we aimed to explore 
whether the TLR signaling pathway and the induction of pro-inflammatory cytokines could 
contribute to the protection against pathogenic microorganisms in vaginal epithelial cells. 
is one of the most potent neutrophil chemoattractants, which affects the ability of 
neutrophils to cross epithelial barriers and to kill bacteria as well [71, 72], In our study, 
microbial compounds induced a strong, time-dependent activation of IL-8 gene in 
»mmortalized vaginal epithelial cells. Our results are in accordance with previous findings 
showing the activation of pro-inflammatory cytokines in vaginal epithelial cells after 
challenge with microbes and indicate that one of the most important immune functions of 
Va8inal epithelial cells might be providing signals for inflammatory cells [30, 73], 
We detected a significant induction of TNF-a mRNA in the cells after treatment with 
L p S , PGN and fungal compounds. However, the soluble TNF-a protein was not detectable in 
t h e supernatants of immortalized vaginal epithelial cells after treatment with microbial 
compounds, using ELISA kits purchased from two different manufacturers. We and other 
authors had similar difficulties with the detection of TNF-a in the supernatants of cultured 
human keratinocytes by ELISA (see above). TNF-a is initially synthesized as a 26-kDa pro-
^ P - a , a type II integral membrane protein, and then is proteolytically cleaved to release a 
mature 17-kDa secreted form [74]. The cleavage of pro-TNF-a occurs primarily at the cell 
surface by specific enzymes [75]. Hence, the produced TNF-a protein may be either stored 
mtracellularly and further microenvironmental stimuli are needed for its release to the 
ejttracellular matrix or it is bound to the cell surface, which could explain the virtual lack of 
this cytokine in the cell culture supernatants. 
53 Examination ofTLR2 and TLR4 polymorphisms in acne 
Growing amounts of data suggest that the ability of certain individuals to respond 
Properly to TLR ligands may be impaired by SNPs within TLR genes, resulting in an altered 
Susceptibility to, or course of, infectious or inflammatory disease [41], Association was found 
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between the occurrence of the two cosegregating polymorphisms of TLR4 (Asp299Gly and 
Thr399lle) and the hyporesponsiveness to inhaled LPS. Investigators also found a clear 
correlation between severe respiratory syncytial virus bronchiolitis in infants and both TLR4 
S N p s . Supporting the role of TLR2 in atopic diseases, the TLR2 Arg753Gln polymorphism 
was shown to define a subgroup of people with atopic dermatitis displaying a severe 
Phenotype [41]. Our recent data have shown that certain P. acnes strains are capable to 
activate the innate immune responses in keratinocytes, and this induction is TLR2 and TLR4 
dependent [76], Beside keratinocytes, sebocytes and professional immune cells, e.g. 
Macrophages, also express TLRs, through which P. acnes can contribute to inflammation at 
t he site of acne lesions [40, 77], Although the polymorphisms and mutations of TLR2 and 
T L R 4 
genes could be hypothesized to contribute to the pathogenesis of acne, the SNPs 
studied here were not proved to assist in the development of acne. The fact that we could not 
find any associations between acne and the studied TLR2 and TLR4 polymorphisms does not 
exclude the possibility that other polymorphisms of these two genes would contribute to acne 
Pathogenesis. Further studies are needed to decide whether additional TLR2 and TLR4 
Polymorphisms are associated with acne and/or whether the reported upregulation of these 
Senes in acne [39] is the result of upstream regulatory events. 
We couldn't detect the TLR2 SNPs causing the amino acid changes Arg677Trp and 
Arg753Gln. This result corresponds to the data in the literature showing that Arg677Trp 
change does not occur and Arg753Gln shows a low allele frequency. According to our 
analysis by two computer programs, these two SNPs, especially the Arg677Trp change, have 
a considerable effect on the protein function and hydrophilicity. Presuming that an alteration 
i n the protein function and hydrophilicity may have an impact on the occurrence of an SNP, 
t h e predicted effect of Arg677Trp and Arg753Gln change may explain why these two SNPs 
are so rare. 
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6. Summary 
Epidermal cells play a role in several immune processes [3, 5], In our study we 
Intended to gain additional data on the innate immune functions of epidermal cells. We have 
investigated the effects of budesonide and tacrolimus on the IL-la , TNF-a and IL-8 
Production and TLR2 and TLR4 expression in HaCaT cell line and in cultured keratinocytes 
isolated from normal human skin. Applying at the same concentration, the effect of these two 
immunosuppressants was different on IL-8, TNF-a, TLR2 and TLR4 genes in keratinocytes. 
This difference might explain the dissimilarity in the effects and side-effects of these two 
dmgs after topical application on the skin. Our results, together with earlier data, confirm the 
cell-surface expression of TLR2 and TLR4 in keratinocytes and vaginal epithelial cells, 
through which these cells are capable of recognizing various kinds of microbial molecular 
Patterns. Playing a role in the innate immune functions of the epidermis, these cells can 
contribute to the pathogenesis of several skin diseases. Data from the literature suggest, that 
TLRs participate in the development of acne [39, 40], hence the mutations and 
Polymorphisms of these genes might have an influence on acne susceptibility. Although our 
s t u d y could not find any associations between acne and the studied TLR2 and TLR4 
Polymorphisms, it does not exclude the possibility that other polymorphisms of these genes 
Would contribute to acne pathogenesis. 
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